Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.37 |
| ▸ | ACACB | O00763 | 1/20 | 0.37 |
| ▸ | ACACA | Q13085 | 1/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | FDPS | P14324 | 3/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.36 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12153331 | 0.97 | CA1 (0.48) | CA1TRPV1TRPA1ACE2LTA4H | |
| SCHEMBL7912103 | 0.90 | CA1 (0.61) | CA1ACE2FAAHFFAR4FFAR1 | |
| SCHEMBL11386622 | 0.90 | CA1 (0.61) | CA1ACE2FAAHFFAR4FFAR1 | |
| SCHEMBL1437768 | 0.90 | CA1 (0.40) | CA1TRPV1TRPA1ACE2LTA4H | |
| SCHEMBL574092 | 0.90 | CA1 (0.61) | CA1ACE2FAAHFFAR4FFAR1 | |
| SCHEMBL13538692 | 0.90 | CA1 (0.61) | CA1ACE2FAAHFFAR4FFAR1 | |
| SCHEMBL13819793 | 0.90 | CA1 (0.61) | CA1ACE2FAAHFFAR4FFAR1 | |
| SCHEMBL13819794 | 0.90 | CA1 (0.61) | CA1ACE2FAAHFFAR4FFAR1 | |
| SCHEMBL13819798 | 0.90 | CA1 (0.61) | CA1ACE2FAAHFFAR4FFAR1 | |
| SCHEMBL2573740 | 0.90 | CA1 (0.61) | CA1ACE2FAAHFFAR4FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8049018-B2 | Methine dyes and uses of the same | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2011-11-01 | — | — | US | disclosed |
| US-8049018-B2 | Methine dyes and uses of the same | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2011-11-01 | — | — | US | disclosed |
| US-20090076278-A1 | METHINE DYES AND USES OF THE SAME | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2009-03-19 | — | — | US | disclosed |
| US-20090076278-A1 | METHINE DYES AND USES OF THE SAME | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2009-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090076278-A1 | METHINE DYES AND USES OF THE SAME | INMT, IDO1, IDO2 | CA1 1201/4885TRPV1 91/4885TRPA1 58/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.